- Home
- LSF vs AEON Comparison
LSF vs AEON Comparison
Compare LSF & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.39
HOLD
Current Price
$0.90
Company Overview
Basic Information| Metric | LSF | AEON |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3M | 26.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSF | AEON |
|---|---|---|
| Price | $2.39 | $0.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $7.20 |
| AVG Volume (30 Days) | 41.4K | ★ 70.9K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $49,889,286.00 | N/A |
| Revenue This Year | $40.85 | N/A |
| Revenue Next Year | $28.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.23 | N/A |
| 52 Week Low | $1.96 | $0.38 |
| 52 Week High | $7.94 | $1.45 |
Technical Indicators
Market Signals| Indicator | LSF | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 38.94 |
| Support Level | $2.41 | $0.87 |
| Resistance Level | $2.76 | $1.12 |
| Average True Range (ATR) | 0.20 | 0.12 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 76.17 | 7.47 |
Price Performance
Historical Comparison LSF
AEON
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.